Article Details

Syngene Q1 FY26 Revenue Up 11% YoY to ₹875 Crore, Net Profit Jumps 59%

Retrieved on: 2025-07-23 14:04:59

Tags for this article:

Click the tags to see associated articles and topics

Syngene Q1 FY26 Revenue Up 11% YoY to ₹875 Crore, Net Profit Jumps 59%. View article details on hiswai:

Excerpt

... monoclonal antibodies, Antibody-Drug Conjugates, Oligonucleotides and PROTACs (proteolysis targeting chimeras).Syngene was recognised by TIME ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo